References

  1. Mandell BF. Acute rheumatic and immunologic disease: management of the critically Ill Patient-1st edition. 1994. Cleveland. Brian Mandell F. Google Scholar

  2. Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med. 2000 Oct 17; 133 (8): 600-3. PubMed | Google Scholar

  3. Moore H, Sheehan H. The kidney of scleroderma. Lancet. 1952 Jan 12; 1(6698): 68-70. PubMed | Google Scholar

  4. Traub YM, Shapiro AP, Rodnan GP et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis; review of a 25 year experience with 68 cases. Medicine (Baltimore). 1983 Nov; 62(6): 335-52. PubMed | Google Scholar

  5. Zbiti N, Houssaini TS, Benkirane A, Alhamany Z et al. Crise rénale sclérodermique. Nephrol Ther. 2010 Dec; 6(7): 606-9. PubMed | Google Scholar

  6. Teixeira L, Servettaz A, Mehrenberger M, Noël LH, Guillevin L, Mouthon L. Crise rénale sclérodermique. Presse Med. 2006 Dec; 35(12 Pt 2): 1966-74. PubMed | Google Scholar

  7. Yanaba K, Asano Y, Tada Y, Sugaya M et al. Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis. Clin Rheumatol. 2012 May; 31(5): 835-9. PubMed | Google Scholar

  8. Guillevin L, Bérezné A, Seror R, Teixeira L et al. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology. 2012 Mar; 51(3): 460-7. PubMed | Google Scholar

  9. Mouthon L, Allanore Y, Cabane J, Hachulla E. Sclérodermie systémique. In : Guillevin L, Meyer O, Sibilia J, dir. Traité des maladies et syndrome systémiques-5th edition. 2008. Paris.Flammarion. Google Scholar

  10. Zadman Goodar G, Tweezer Z, Shalev T et al. A novel overlap syndrome. Ann NY Acad Sci. 2007; 1108:497-504. PubMed | Google Scholar

  11. Kobayashi H, Nichimaki T, Kaise S et al. Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis. Clin Rheumatol. 1999; 18(5): 425-7. PubMed | Google Scholar

  12. D'agnelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar; 46(3): 428-40. PubMed | Google Scholar

  13. Gonzalez EA, Schmulbach E, Bastani B. Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis. Am J Kidney Dis. 1994; 23(2): 317-9. PubMed | Google Scholar

  14. Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. Qjm. 2007 Aug; 100(8): 485-94. PubMed | Google Scholar

  15. Teixeira L, Mouthon L, Mahr A et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis. 2008 Jan; 67(1): 110-6. PubMed | Google Scholar

  16. Dijou F, McGregor B. Sclérodermie systémique. In: Noel LH, dir. Atlas de pathologie rénale-1st edition. 2008. Paris. Google Scholar

  17. Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med. 2000 Oct 17; 133(8): 600-3. PubMed | Google Scholar

  18. Denton CP, Black CM. Scleroderma--clinical and pathological advances. Best Pract Res Clin Rheumatol. 2004 Jun; 18(3): 271-90. PubMed | Google Scholar

  19. Steen V. Scleroderma renal crisis. Indian J Med Sci. 2007 Feb; 61(2): 71-2. PubMed | Google Scholar